$5.8 Billion, page-15

Yes, yes, malmanu. Your rejoinder is totally appropriate. I guess what I really was saying was that it's great to find someone who agrees with my dream (I admit it's a dream until favourable announcements) that strongly positive CHF interim results will release a tidal wave, a tsunami of instos battling to balance their portfolios to include what could become the greatest blockbuster biotech share of all time ( my 50 years of medical experience backs the latter opinion).

There really are numerous individuals suffocating to death at this moment, and their distressed families, who would pay cash for MPC-150-IM today, almost regardless of price. If the looming interim results confirm earlier extraordinary benefit, the FDA wil be under irresistible pressure to approve the product. I recall another poster, obviously experienced in this area, casting doubt on that scenario of FDA softening their traditional cynicism. I respect that scientific opinion but I much more favour the likelihood of a politically driven response. Good interim CHF results will be bankable to holders.